The third phase of clinical trials for a COVID-19 vaccine has begun in Abu Dhabi.
The chairman of the Department of Health- Abu Dhabi (DoH), Sheikh Abdullah bin Mohammed Al Hamed is the first person to participate in the trial.
Dr. Jamal Al Kaabi, Acting Undersecretary of DoH will be the second in line.
The trials are being performed by Abu Dhabi-based G42 Healthcare in cooperation with China's Sinopharm CNBG, under the administration of the DoH and the UAE's Ministry of Health.
عبد الله بن محمد آل حامد، رئيس دائرة الصحة بأبوظبي، أول متطوع يشارك في التجارب السريرية التي تجري في #أبوظبي للمرحلة الثالثة من اللقاح غير النشط لوباء كوفيد-19، يليه الدكتور جمال الكعبي، وكيل دائرة الصحة بالإنابة، وهو الأمر الذي يعكس التزام الإمارة بإيجاد علاج عالمي للوباء. pic.twitter.com/TX6AJPxJh3
— مكتب أبوظبي الإعلامي (@ADMediaOffice) July 16, 2020
It's the world’s first WHO-listed phase III clinical trial of the COVID-19 inactivated vaccine.
The world’s first @WHO-listed phase III clinical trial of the Covid-19 inactivated vaccine has begun in #AbuDhabi, with @DoHSocial Chairman, Sheikh Abdullah bin Mohammed Al Hamed the 1st to participate in the trial, followed by Acting Undersecretary Dr. Jamal Al Kaabi. pic.twitter.com/gEIFgcSFHC
— مكتب أبوظبي الإعلامي (@ADMediaOffice) July 16, 2020
The UAE's plans to launch the trials were announced last month, while earlier this week, Minister of Health and Prevention, Dr. Abdul Rahman Al Owais revealed more than 15,000 volunteers will be participating.
UAE dispatches search-and-rescue teams, relief aid to Sri Lanka
UAE leaders receive greetings on 54th Eid Al Etihad
Sharjah Ruler inaugurates Independence Square project
Mansour bin Zayed to lead UAE delegation at 46th GCC Summit
UAE leaders post special social media messages to wish 54th Eid Al Etihad
